1. Hypolipidemic Agents Sachin Kuchya,MD Assistant Professor, Department of Pharmacology NSCB Medical College, Jabalpur 2. Why do we need them? Low HDL & elevated LDL-c…

Slide 1 Attualità nellimpiego delle statine Prof. P. Pauletto Dip. di Medicina Clinica e Sperimentale Università degli Studi di Padova U.O. di Medicina Interna I^ U.L.S.S.…

NCEP ATP IV Guidelines: Whatâs New in 2012? NCEP ATP IV GuidelineS: 2013 Update The National Cholesterol Education Program Adult Treatment Panel guidelines, national guidelines…

Slide 1Statins and CAD Prevention: Rosuvastatin Slide 2 Rising burden of CVD in India (2005) Lancet 2005;366:1744-9 Estimated proportions of total deaths and DALYs lost by…

Slide 1 Presenter Disclosure Information Paul M Ridker, MD, FACC Dr Ridker is listed as a co-inventor on patents held by the Brigham and Women’s Hospital that relate to…

Slide 1 04/16 CARD-1063303-0004 Date of preparation May 2014 LDL-Cholesterol – Lower is Better Reducing CHD in high risk patients Slide 2 04/16 CARD-1063303-0004 Date of…

Slide 1 HDL CHOLESTEROL REVISITED-- A RELIABLE DIAGNOSTIC TOOL OR JUST A PASSING FANCY? GARY A. LOPEZ, M.D. Slide 2 Disclosures None Slide 3 Atherosclerotic Heart Disease…

REVIEW Open Access Fibrates are an essential part of modern to placebo or other fibrates. Among major fibrates, bezafibrate appears to have the strongest and fenofibrate…

Slide 1 Virginia ACP MSFM Session - Lipid Management & CVD Risk Reduction - Q1. What is the evidence that adding a second pharmacologic agent to statin therapy improves…

Slide 1 Lipids: Is Lower Better For Diabetic Patients? Prof. Samir Helmy Assaad -Khalil Department of Internal Medicine Unit of Diabetes, Lipidology & Metabolism Alexandria…